New preclinical research shows a gene already linked to a subset of people with autism spectrum disorder is critical to healthy neuronal connections.
Researchers at King’s College London have shown that rats with spinal cord injuries can re-learn skilled hand movements after being treated with a gene therapy.
Genomic data company, Fabric Genomics have said its proprietary clinical genomics platform has been selected by 10 new commercial partners across Africa, Asia, Europe and North America.
A new report released at the BIO International Convention shows that the US bioscience industry has had a $2-trillion economic impact and has accelerated venture capital investment and job growth.
A look behind the scenes at some of the logistics involved in keeping CRISPR proliferating throughout the scientific world.
Multiomics Approaches to Biomarker Discovery in Cardiovascular Disease: Smoking, Cessation, and Reduced-Risk-Products
At the recent European Atherosclerosis Society annual meeting in Lisbon, Portugal, Philip Morris International (PMI) scientists presented posters of two studies that make extensive use of systems biology methods.
PetaSuite Cloud Edition genomic data compression software brings PetaGene its second, “Best of Show” award at Bio-IT World.
Open access dataset reveals how factors such as diet, antibiotics and mental health status can influence the microbial and molecular makeup of your gut.
Repositive, has successfully concluded the pilot phase of its data-sharing platform for PDX cancer models and is now extending the scope of the platform to include a wider range of translational cancer models.
Karius has developed a next-generation sequencing test for microbial cell-free DNA that provides clinicians with a comprehensive test capable of identifying more than 1,250 pathogens directly from blood.
Cofactor Genomics, the developer of advanced RNA analysis tools, has announced that it has entered into an agreement with the National Cancer Institute, to demonstrate the clinical utility of its immune-profiling assay, Cofactor Paragon.
ArcherDX, a company known for producing NGS-based gene fusion detection assays, has closed a $35 million Series A preferred financing,
Designed to accelerate pre-clinical genomic research and drug discovery for the benefit of patients, the team behind the global genomic data marketplace has grown by nearly 50% in the past year.
New research shows that a test for measuring the length of DNA endcaps called telomeres can alter treatment decisions for patients with certain types of bone marrow failures.
QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing in second half 2018 in Europe and later in the U.S.